The chemical class termed MPP7 Activators encompasses a broad spectrum of compounds that indirectly influence the functionality of the MPP7 protein, predominantly through the modulation of cellular signaling pathways rather than direct interaction with MPP7 itself. These activators are characterized by their diverse mechanisms of action, each targeting different aspects of cellular communication and regulation. For instance, compounds like Forskolin and IBMX work by elevating intracellular cyclic AMP (cAMP) levels, thereby enhancing MPP7 activity through cAMP-dependent pathways. This increase in cAMP is crucial as it serves as a secondary messenger in various cellular processes, amplifying the effects of primary signals. Similarly, compounds such as Anisomycin and PMA (Phorbol 12-myristate 13-acetate) activate specific protein kinases like JNK and PKC, respectively. Activation of these kinases can lead to a cascade of phosphorylation events, ultimately influencing the activity of MPP7. These phosphorylation events are pivotal in regulating protein function and signaling pathways within the cell.
Furthermore, the modulation of calcium signaling by compounds such as Ionomycin and A23187 (Calcimycin) presents another avenue through which MPP7 activity can be influenced. These compounds increase intracellular calcium levels, a critical second messenger in numerous cellular processes, affecting MPP7's role in these pathways. Additionally, the chemical class includes compounds like Sildenafil and Zaprinast, which inhibit phosphodiesterase 5 (PDE5), leading to increased cyclic GMP (cGMP) levels. This rise in cGMP can have significant effects on cellular signaling pathways, possibly impacting MPP7 activity. The action of these compounds illustrates the interconnected nature of cellular signaling networks, where altering the balance of second messengers like cAMP and cGMP can have far-reaching effects on various proteins and pathways, including those in which MPP7 is involved. The diversity in the mechanisms of action of these compounds highlights the complexity and intricacy of cellular signaling and underscores the ability of these activators to modulate MPP7 activity in a cellular context.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, which could enhance MPP7 activity through cAMP-dependent pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Acts as a JNK activator, potentially influencing MPP7 activity through the JNK signaling pathway. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Elevates intracellular calcium, potentially affecting MPP7 activity through calcium signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ionophore that increases intracellular calcium, potentially influencing MPP7 via calcium signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, potentially modulating MPP7 activity through PKC-mediated pathways. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Acts on G-protein coupled receptors, potentially affecting MPP7 activity through these pathways. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $33.00 $124.00 $218.00 $947.00 | 9 | |
Increases cGMP levels by activating soluble guanylate cyclase, potentially affecting MPP7 activity. | ||||||